| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/17/2007 | CN1895480A Plaster for neck, should, waist and leg paralysis |
| 01/17/2007 | CN1895464A Decoction medicine for treating acute appendictis and its preparation |
| 01/17/2007 | CN1895461A Preparation of dyers woad root injection |
| 01/17/2007 | CN1895436A Huxin infusion granule |
| 01/17/2007 | CN1895403A Compound Chinese medicine for treating bone stitch and its preparation |
| 01/17/2007 | CN1895382A Anti-inflammatory and heat-relieving Chinese-herb preparation |
| 01/17/2007 | CN1895364A Decumbent corydalis Rhizome medicinal composition for treating cerebral thrombosis sequela and rheumatic arthritis |
| 01/17/2007 | CN1895356A Chinese-medicinal preparation with clearing heat and anti-inflammatory functions and its making method |
| 01/17/2007 | CN1895324A Jinganmin dispersing tablets and preparation thereof |
| 01/17/2007 | CN1895323A Jinganmin oral disintegrant tablets and preparation thereof |
| 01/17/2007 | CN1895311A Hydrophilic gel pleximetric paste and its preparation |
| 01/17/2007 | CN1895309A Lysiontus pauciflorus preparation and its making method |
| 01/17/2007 | CN1895261A Use of pokeroot saponin A in preparation medicine for treating rheumatoid arthritis |
| 01/17/2007 | CN1895258A Diflunisal slow-releasing preparation and its making method |
| 01/17/2007 | CN1895242A Diclofenac salt pleximetric paste and its production |
| 01/17/2007 | CN1895239A Curcumin preparation and its making method |
| 01/17/2007 | CN1895221A Fast-effective oral analgesic |
| 01/17/2007 | CN1295245C Dengxin subergorgia saponin |
| 01/17/2007 | CN1295227C Barbituric acid derivs with antimetastatic and antitumor activity |
| 01/17/2007 | CN1295224C Process for preparing epimedium total flavone for injection |
| 01/17/2007 | CN1295221C Substituted heterocyclic compounds |
| 01/17/2007 | CN1295213C Fluorinated cycloalkyl-derivatized benzoylguanidines and their uses as medicament |
| 01/17/2007 | CN1294975C Medicine for alleviating pain of cancer |
| 01/17/2007 | CN1294974C Plaster for treating rheumatoid, fracture, sprain and arthritis and preparation method thereof |
| 01/17/2007 | CN1294942C Pain stopping capsule |
| 01/17/2007 | CN1294940C Chinese medicinal preparation for treating rheumatic and homologus rheumatic artbritis |
| 01/17/2007 | CN1294920C Medicine prepared with cactus and taraxacum |
| 01/17/2007 | CN1294917C Injection for curing italitai disease |
| 01/17/2007 | CN1294910C Medicinal composition having antiseptic and anti-inflammatory function |
| 01/16/2007 | US7164027 Aralkyl ester soft drugs |
| 01/16/2007 | US7164000 RANTES mutants and therapeutic applications thereof |
| 01/16/2007 | US7163960 Treatment and prevention of inflammatory disorders |
| 01/16/2007 | US7163958 Compositions comprising nitrosated NSAID and compound that donates, transfers or releases nitric oxide, or stimulates endogenous synthesis of nitric oxide; treatment of inflammation, pain, fever, gastrointestinal disorders |
| 01/16/2007 | US7163951 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 01/16/2007 | US7163940 Pyrazolopyridinyl pyrimidine therapeutic compounds |
| 01/16/2007 | US7163930 Pharmaceutical compositions and methods relating to fucans |
| 01/16/2007 | US7163824 Cell containing nucleic acid molecule comprising polynucleotide sequence encoding engineered zinc finger protein operably linked to promoter, contacting target site in endogenous cellular gene with protein to inhibit transcription |
| 01/16/2007 | US7163681 Isolated monoclonal antibody comprising a light and heavy chain variable of given sequence; diagnosing, treating and preventing prostate/colon cancer and renal carcinoma |
| 01/16/2007 | CA2263911C Treatment of autoimmune diseases |
| 01/16/2007 | CA2208746C Novel immunotherapeutic aryl amides |
| 01/11/2007 | WO2007006041A2 Imaging and therapeutic method using monocytes |
| 01/11/2007 | WO2007005510A1 N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase |
| 01/11/2007 | WO2007005403A1 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as cxc-chemokine receptor ligands |
| 01/11/2007 | WO2007005177A1 Alpha-2 adrenergic agonists for the treatment of pain |
| 01/11/2007 | WO2007005174A2 4- (3 -hydroxy- and 3-aminomethyl-cyclohexen-3-ylmethyl) 1, 3-dihydroimdazole-2-thione derivatives as alpha-2 adrenergic agonists |
| 01/11/2007 | WO2007004979A1 Method for modulating responsiveness to steroids |
| 01/11/2007 | WO2007004977A1 Immunostimulatory method |
| 01/11/2007 | WO2007004958A1 Pyridopyrimidine derivatives as pde4 inhibitors for the treatment of inflammatory and' immune diseases |
| 01/11/2007 | WO2007004733A1 ACTIVATOR OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR δ |
| 01/11/2007 | WO2007004675A1 Drug-containing photocrosslinked hyaluronic acid derivative gel |
| 01/11/2007 | WO2007004543A1 Pharmaceutical composition comprising 2-pyridone derivative as active ingredient |
| 01/11/2007 | WO2007003536A1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect |
| 01/11/2007 | WO2007003422A1 Crystalline forms of macrolide compounds endowed with antiinflammatory activity |
| 01/11/2007 | WO2006121390A3 Benzoic acid derivatives that are modulators or agonists of glyr |
| 01/11/2007 | WO2006120481A3 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones which modulate the function of the vanilloid-1 receptor (vr1) |
| 01/11/2007 | WO2006074192A3 Treatment of inflammatory disorders |
| 01/11/2007 | WO2006072792A3 Compounds which bind to the active site of protein kinase enzymes |
| 01/11/2007 | US20070010658 Trimeric binding proteins for trimeric cytokines |
| 01/11/2007 | US20070010569 4-Methyl-5-(2-oxo-1,2-dihydroindol-3- ylidenemethyl)-1H-pyrrole-2- carboxylic acid; cancer |
| 01/11/2007 | US20070010563 Novel methods for the treatment of inflammatory diseases |
| 01/11/2007 | US20070010555 Indazole having analgesic activity |
| 01/11/2007 | US20070010551 Quinoline derivatives as neutrophil elastase inhibitors and their use |
| 01/11/2007 | US20070010549 Imidazo(4,5-b)pyridine-derivatives as inducible no-synthase inhibitors |
| 01/11/2007 | US20070010530 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 01/11/2007 | US20070010529 Nitrogenous heterocyclic compounds and medical use thereof |
| 01/11/2007 | US20070010521 Condensed polycyclic compounds |
| 01/11/2007 | US20070010517 Pharmaceutical salts of reboxetine |
| 01/11/2007 | US20070010515 [1,2,4] Triazolo [1,5, a] pyrimidin-2-ylurea derivative and use thereof |
| 01/11/2007 | US20070010497 Pharmaceutical composition comprising a p2x7 antagonist and sulfasalazine |
| 01/11/2007 | US20070010483 Glucocerebroside treatment of liver disorders |
| 01/11/2007 | US20070010473 Nucleic acid ligands to integrins |
| 01/11/2007 | US20070010457 Caspase inhibitors and uses thereof |
| 01/11/2007 | US20070010430 Proteoglycan isolated from cartilaginous fish and process for producing the same |
| 01/11/2007 | US20070009520 Osteoclastogenesis inhibitory factor-binding molecule (OBM) specific immunoglobulin for use inhibiting osteoclast inhibitory factor (OCIF) binding activity and treating bone disorders |
| 01/11/2007 | US20070009514 Prostaglandin receptor ep1 |
| 01/11/2007 | US20070009513 Novel method of screening |
| 01/11/2007 | US20070009507 Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis |
| 01/11/2007 | US20070009469 Treatment of skin, and wound repair, with thymosin beta 4 |
| 01/11/2007 | CA2650656A1 Cytokine receptor modulators and uses thereof |
| 01/11/2007 | CA2614315A1 Activator of peroxisome proliferator activated receptor d |
| 01/11/2007 | CA2614312A1 Drug-introduced photo-crosslinked hyaluronic acid derived gel |
| 01/11/2007 | CA2613911A1 Crystalline forms of macrolide compounds endowed with antiinflammatory activity |
| 01/11/2007 | CA2613428A1 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as cxc-chemokine receptor ligands |
| 01/11/2007 | CA2613059A1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect, process for their manufacture and use thereof as medicaments |
| 01/11/2007 | CA2612241A1 Human monoclonal antibodies to programmed death ligand 1 (pd-l1) |
| 01/11/2007 | CA2612162A1 Use of oligonucleotides in steroid refractory or steroid dependent inflammatory conditions |
| 01/11/2007 | CA2603044A1 Alpha-2 adrenergic agonists for the treatment of pain |
| 01/10/2007 | EP1741780A2 High affinity oligonucleotide ligands to growth factors |
| 01/10/2007 | EP1741779A2 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine mediated toxicity |
| 01/10/2007 | EP1741722A2 Polymorphisms in the human P2X7 gene |
| 01/10/2007 | EP1741702A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
| 01/10/2007 | EP1741447A2 Combinations comprising dipeptidylpeptidase-IV inhibitors and antidiabetic agents |
| 01/10/2007 | EP1741446A2 Combinations comprising dipeptidylpeptidase-IV inhibitors and antidiabetic agents |
| 01/10/2007 | EP1741445A2 Combinations comprising dipeptidylpeptidase-IV inhibitors and antidiabetic agents |
| 01/10/2007 | EP1741441A1 Bone densifying agent characterized by use of cathepsin k inhibitor with pth |
| 01/10/2007 | EP1741428A2 Cell adhesion inhibitors |
| 01/10/2007 | EP1740590A1 PYRAZOLO [3,4- b] PYRIDINE COMPOUNDS, AND THEIR USE AS PDE4 INHIBITORS |
| 01/10/2007 | EP1740583A1 Oxadiazolone derivatives as ppar delta agonists |
| 01/10/2007 | EP1740578A1 4- 2- (cycloalkylamino) pyrimidin-4-yl ] - (phenyl) - imidazolin-2- one derivatives as p38 map- kinase inhibitors for the treatment of inflammatory diseases |
| 01/10/2007 | EP1740561A2 Arylphenylamino-and arylphenylether-sulfide derivatives, useful for the treatment of inflammatory and immune diseases, and pharmaceutical compositions containing them |